Breast cancer
Results
Phase 3
This trial compared different ways of giving zoledronic acid for breast cancer that has spread to the bones. This trial was supported by Cancer Research UK.
Recruitment start: 20 March 2006
Recruitment end: 4 August 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Coleman
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Novartis
University of Leeds
University of Sheffield
This is Cancer Research UK trial number CRUK/05/18.
Last reviewed: 27 November 2012
CRUK internal database number: 852
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
